Overall and worst gleason scores are equally good predictors of prostate cancer progression

por Tolonen, Teemu T, Kujala, Paula M, Tammela, Teuvo LJ, Tuominen, Vilppu J, Isola, Jorma J, Visakorpi, Tapio
Publicado 2011

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer

por Ola, Idris Olasunmbo, Talala, Kirsi, Tammela, Teuvo, Taari, Kimmo, Murtola, Teemu, Kujala, Paula, Raitanen, Jani, Auvinen, Anssi
Publicado 2022

Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology

por Hartmann, Sylvia, Eray, Mine, Döring, Claudia, Lehtinen, Tuula, Brunnberg, Uta, Kujala, Paula, Vornanen, Martine, Hansmann, Martin-Leo
Publicado 2014

Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data

por Booth, Neill, Rissanen, Pekka, Tammela, Teuvo L. J., Kujala, Paula, Stenman, Ulf-Håkan, Taari, Kimmo, Talala, Kirsi, Auvinen, Anssi
Publicado 2019

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer

por Talala, Kirsi, Heinävaara, Sirpa, Taari, Kimmo, Tammela, Teuvo L. J., Kujala, Paula, Stenman, Ulf‐Håkan, Malila, Nea, Auvinen, Anssi
Publicado 2020

Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study

por Tolonen, Teemu T, Isola, Jorma, Kaipia, Antti, Riikonen, Jarno, Koivusalo, Laura, Huovinen, Sanna, Laurila, Marita, Porre, Sinikka, Tirkkonen, Mika, Kujala, Paula
Publicado 2015

Prognostic Index for Predicting Prostate Cancer Survival in a Randomized Screening Trial: Development and Validation

por Neupane, Subas, Nevalainen, Jaakko, Raitanen, Jani, Talala, Kirsi, Kujala, Paula, Taari, Kimmo, Tammela, Teuvo L. J., Steyerberg, Ewout W., Auvinen, Anssi
Publicado 2021

Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours

por BUGAEVA, Olga, MALINIEMI, Pilvi, PRESTVIK, Wenche S., LEIVO, Eeva, KLUGER, Nicolas, SALAVA, Alexander, VIRTANEN, Sanna, JÄNTTI, Kirsi, SAKSELA, Olli, LEHTI, Kaisa, KUJALA, Paula, KROHN, Kai, RANKI, Annamari
Publicado 2023

Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study

por Rannikko, Antti, Leht, Mare, Mirtti, Tuomas, Kenttämies, Anu, Tolonen, Teemu, Rinta‐Kiikka, Irina, Kilpeläinen, Tuomas P., Natunen, Kari, Lilja, Hans, Lehtimäki, Terho, Raitanen, Jani, Kujala, Paula, Ronkainen, Johanna, Matikainen, Mika, Petas, Anssi, Taari, Kimmo, Tammela, Teuvo, Auvinen, Anssi
Publicado 2022

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

por Nurminen, Anssi, Jaatinen, Serafiina, Taavitsainen, Sinja, Högnäs, Gunilla, Lesluyes, Tom, Ansari-Pour, Naser, Tolonen, Teemu, Haase, Kerstin, Koskenalho, Antti, Kankainen, Matti, Jasu, Juho, Rauhala, Hanna, Kesäniemi, Jenni, Nikupaavola, Tiia, Kujala, Paula, Rinta-Kiikka, Irina, Riikonen, Jarno, Kaipia, Antti, Murtola, Teemu, Tammela, Teuvo L., Visakorpi, Tapio, Nykter, Matti, Wedge, David C., Van Loo, Peter, Bova, G. Steven
Publicado 2023

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine

por Jasu, Juho, Tolonen, Teemu, Antonarakis, Emmanuel S., Beltran, Himisha, Halabi, Susan, Eisenberger, Mario A., Carducci, Michael A., Loriot, Yohann, Van der Eecken, Kim, Lolkema, Martijn, Ryan, Charles J., Taavitsainen, Sinja, Gillessen, Silke, Högnäs, Gunilla, Talvitie, Timo, Taylor, Robert J., Koskenalho, Antti, Ost, Piet, Murtola, Teemu J., Rinta-Kiikka, Irina, Tammela, Teuvo, Auvinen, Anssi, Kujala, Paula, Smith, Thomas J., Kellokumpu-Lehtinen, Pirkko-Liisa, Isaacs, William B., Nykter, Matti, Kesseli, Juha, Bova, G. Steven
Publicado 2021